A training network for the rational design of the next generation of well-defined glycoconjugate vaccines

Project Information

GLYCOVAX

Grant agreement ID: 675671

DOI

10.3030/675671

Project closed

EC signature date 11 August 2015

Start date 1 November 2015

End date 31 October 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 3 554 499,69

EU contribution

€ 3 554 499,69

Coordinated by

GLAXOSMITHKLINE VACCINES SRL
Italy

• Faster future vaccine design
  EN